Dermira (DERM) Tops Q3 EPS by 24c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BE
8. FIX
9. NDAQ
10. TSCO

Go back to Dermira (DERM) Tops Q3 EPS by 24c

Dermira Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 5, 2019 4:05 PM EST

- QBREXZA® (glycopyrronium) cloth net product sales of $10.2M

- Phase 3 lebrikizumab program initiated in adult and adolescent patients with moderate-to-severe atopic dermatitis

- Conference call today at 1:30 p.m. PT / 4:30 p.m. ET

MENLO PARK, Calif.--(BUSINESS WIRE)-- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today reported financial results for the quarter ended September 30, 2019 and provided a corporate update.

The third quarter... More